NorthWest Biotherapeutics Inc (NWBO)

[Evaluate]

you wrote::

I would hope that TLD is revealed before the ASM. I don't believe any investors would be happy to hear again "ginormous", "soon", "stay tuned", "we are nearly there", "just a bit more to tie up loose ends", etc. Then we are easily looking at ASCO 2020 at the earliest.
It would also signal that there is a hold up by RAs in "approving" the SAP.
LP made a statement, as I recall, of obtaining RA approval on the SAP.
If that is so, then, contrary to DI statements in telecon conversations, the RAs must respond either with comments, rejection, or approval.
Then, if as LP has indicated, "approval" of the SAP is required, for the jurisdictions applied for, then NWBO is handcuffed and cannot go forward with this SAP until "approved".

I think all the above in red is incorrect.
I do not believe LP nor anyone else at NWBO made any statement that any of the 4 RAs would need to "approve" the SAP.
Instead, NWBO felt it would be wise to allow the RAs to take a look at the draft SAP, and be able to provide any comments, if desired, in regards to the draft SAP.
If no comments are received from any of the SAPs after a (relatively) short period of time, then I get the impression that NWBO would move along to produce a Final SAP, even without RA input.
NWBO was just hoping that the RAs might "buy-in" to their draft SAP and the data analysis concepts put forth therein. IMO.